Hannisdal E - Search Results

1

Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers.

Lopes JM, Hannisdal E, Bjerkehagen B, Bruland OS, Danielsen HE, Pettersen EO, Sobrinho-Simões M, Nesland JM. Lopes JM, et al. Among authors: hannisdal e. Anal Cell Pathol. 1998;16(1):45-62. doi: 10.1155/1998/545906. Anal Cell Pathol. 1998. PMID: 9584899 Free PMC article. Review.

2

Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.

Ottestad L, Pettersen EO, Nesland JM, Hannisdal E, Fosså SD, Tveit KM. Ottestad L, et al. Among authors: hannisdal e. Pathol Res Pract. 1993 May;189(4):405-10. doi: 10.1016/S0344-0338(11)80327-4. Pathol Res Pract. 1993. PMID: 8351241

3

Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients.

Reed W, Flørems VA, Holm R, Hannisdal E, Nesland JM. Reed W, et al. Among authors: hannisdal e. Virchows Arch. 1999 Aug;435(2):116-24. doi: 10.1007/s004280050408. Virchows Arch. 1999. PMID: 10599310

4

Pregnancy and breast cancer: a population-based study.

Reed W, Hannisdal E, Skovlund E, Thoresen S, Lilleng P, Nesland JM. Reed W, et al. Among authors: hannisdal e. Virchows Arch. 2003 Jul;443(1):44-50. doi: 10.1007/s00428-003-0817-z. Epub 2003 May 20. Virchows Arch. 2003. PMID: 12756565

5

Colony forming ability of human breast carcinomas: lack of prognostic significance.

Ottestad L, Tveit KM, Hannisdal E, Skrede M, Nesland JM, Gundersen S, Pihl A. Ottestad L, et al. Among authors: hannisdal e. Br J Cancer. 1989 Aug;60(2):216-9. doi: 10.1038/bjc.1989.254. Br J Cancer. 1989. PMID: 2765368 Free PMC article.

6

Colony-forming ability of human ovarian carcinomas in the Courtenay soft agar assay.

Tveit KM, Kaern J, Hoifodt HK, Pettersen EO, Abeler V, Davy M, Hannisdal E, Trope C. Tveit KM, et al. Among authors: hannisdal e. Anticancer Res. 1989 Nov-Dec;9(6):1577-82. Anticancer Res. 1989. PMID: 2483300

7

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.

Reed W, Hannisdal E, Boehler PJ, Gundersen S, Host H, Marthin J. Reed W, et al. Among authors: hannisdal e. Cancer. 2000 Feb 15;88(4):804-13. doi: 10.1002/(sici)1097-0142(20000215)88:4<804::aid-cncr11>3.0.co;2-y. Cancer. 2000. PMID: 10679650

8

Expression of CD18 (integrin beta 2 chain) correlates with prognosis in malignant B cell lymphomas.

Erikstein BK, Holte H, Kvaløy S, Andersson KB, Steen HB, Hannisdal E, Smeland EB. Erikstein BK, et al. Among authors: hannisdal e. Br J Haematol. 1993 Mar;83(3):392-8. doi: 10.1111/j.1365-2141.1993.tb04662.x. Br J Haematol. 1993. PMID: 8097923

9

Host markers and prognosis in recurrent rectal carcinomas treated with radiotherapy.

Hannisdal E, Tveit KM, Theodorsen L, Høst H. Hannisdal E, et al. Acta Oncol. 1994;33(4):415-21. doi: 10.3109/02841869409098438. Acta Oncol. 1994. PMID: 8018375

10

Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy.

Hannisdal E, Fosså SD, Høst H. Hannisdal E, et al. Radiother Oncol. 1993 May;27(2):117-22. doi: 10.1016/0167-8140(93)90131-q. Radiother Oncol. 1993. PMID: 8356221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page